- Staat
- LA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Syncope
Symptomtext
Administered both vaccines on 10/14/22 - second in the series of both (no problems noted with the first dose administered to the patient in the series). Vasovagal syncope noted approximately 20 minutes after vaccines administered. Patient was sent to hospital to be assessed; not admitted. Follow-up call patient had no problems to report on 10/19/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Myasthenia Gravis
- Andere Medikamente
- -
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 22.08.2022
- Impfdatum
- 22.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Electrocardiogram
Heart rate decreased
Hypotension
Syncope
Symptomtext
Syncope, patient didn't completely pass out, but wasn't alert. Blood pressure was low and HR was low. Patient sat down in chair for 15 mins while we waited for ambulance. By the time ambulance arrived patient's BP and HR was back to normal levels.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- BP reading, EKG, Heart Rate, and Oxygen saturation
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 15.08.2022
- Impfdatum
- 15.08.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
Pt tolerated injections well then walked out of examination room with father to waiting area and sat down and within 5 min sank into his chair and his father had ahold of him so he did not fall out of the chair (pt may have lost consciousness for less than a min) when staff arrived to assist. pt's eyes were open and he was responding to staff. Father stated he has had this happen after having a blood draw before (staff was not informed of this ahead of time). Pt was walked with staff and father back into the examination room and laid down on exam room table for 15 min. Patient was talkative the entire time he was in the examination room and stated he felt fine. Pt was fine and able to leave walking out on his own with his father.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- denies
- Vorgeschichte
- denies
- Andere Medikamente
- denies
- Allergien
- denies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 11.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dizziness
Pallor
Syncope
Symptomtext
Approximately 5 minutes after vaccination, patient complained of feeling light-headed. His face appeared pale and he attempted to walk a couple of steps to get on the exam table and began to faint. He was caught by myself and his mother and guided to the floor without injury. The initial episode was very brief (seconds) and the patient was conscious and speaking by the time he was completely supine on the floor. He was provided a cool compress to the forehead for approximately 3 minutes until he felt able to stand to get to the table. Once flat on the table with legs raised, he was provided apple juice until he was able to sit and eventually stand and then walk to the car without light-headedness (approximately 20 minutes).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 09.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Seizure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- history of idiopatic seizure
- Andere Medikamente
- vitamin D multivitamin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 16.08.2022
- Impfdatum
- 16.08.2022
- Beginn
- 16.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Symptomtext
3 minutes after patient received the vaccine, patient experienced lightheadedness and dizziness and fell forward from a standing position. Pharmacist caught the patient, and laid him onto the ground. Patient was responsive and was then moved to sit on a chair. Patient received water, felt better, and was able to leave the pharmacy with his dad after 10 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 15.08.2022
- Impfdatum
- 12.08.2022
- Beginn
- 12.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Injection site swelling
Swelling
Tenderness
Symptomtext
Patient is having ball like swelling at the injection site in the left arm. Patient states that there is redness, tenderness and swelling. Patient states that it started the night of the vaccination 8/12/2022. Patient came back to the clinic today 8/15/2022. Patient and MOC state that the swelling has gotten larger. MOC states that they have tried ibuprofen and that has not helped.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 01.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Neck pain
Pain in jaw
Symptomtext
Pain @ site that went up to the Jaw neck and down arm Swelling @ site;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- KNDA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 01.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site rash
Injection site swelling
Neck pain
Pain
Swelling
Symptomtext
Pain & swelling at site, swelling in axilla area rash from site down to elbow. Pain in collarbone are and chest with exertion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Multivitamin, Albuterol Sulfate inhaler
- Allergien
- Doxycycline
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 03.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 03.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Dysstasia
Feeling hot
Loss of personal independence in daily activities
Pallor
Symptomtext
Patient got light-headed, and was unable to stand without assistance. Patient remained conscious, but said he felt like he was going to pass out. He was pale and said he was hot. The patient was seated, his color came back relatively quickly. His mother gave him a drink and he seemed to feel better relatively quickly. His mother reported that this has happened previously with doctor visits and he gets nervous with vaccines. A follow-up call was made to his mother and she reported he was completely fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Erythema
HIV test
Herpes virus test
Injection site macule
Laboratory test
Rash macular
Skin warm
Treponema test
Symptomtext
He received the first dose of Monkeypox vaccine and 2 hours later he noticed a vesicle/blister growing on the right arm,. The blister is 1 cm. diameter, surrounded by an erythematous area, and it is hotter than the skin. He has one more macular lesion on the same arm and 3 little macular lesions on the left arm under the vaccine injection site. The case feels good, doesn't have breathing problems, or any other kind of skin rash
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site macule
- Hospital-Tage
- -
- Labordaten
- the lesion was swab to test for Monkeypox, and herpes virus. We also took blood samples for syphilis and HIV.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- high cholesterol, depression, anxiety, overweight
- Andere Medikamente
- gabapentine, sertraline, aspirin (81 mg) Coquid, magnesium, zinc, tumeric
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Eye swelling
Rash
Symptomtext
pt says she noticed a rash in her armpits on 7/24/22 at 10pm, then at midnight she had rash waist on up, has slightly swollen eyes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 13.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hyperhidrosis
Pallor
Symptomtext
Client received a Tdap and MCV4 vaccine After sitting in biosafety area, client reported feeling faint, pale and diaphoretic. Client was assessed and noted responsive at all times, awake and alert. Immediately feeling better. Client was responsive, awake and alert left with family at 1910.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 20.11.2023
- Impfdatum
- 08.11.2023
- Beginn
- 08.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
expired menactra vaccine to a consumer with no reported adverse event; Initial information was received on 08-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 17 years old female patient who received an expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] vaccine to a consumer with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV VACCINE (HPV VACCINE) and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for Prophylactic vaccination. On 08-Nov-2023, the patient received 0.5 ml of expired (30-Oct-23) of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U7492AA) (strength: unknown) (expired product administered, latency same day) via intramuscular route in the deltoid nos for prophylactic vaccination (Immunization). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HPV VACCINE; TDAP
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.11.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
Pharmacist states that one of their patient received an expired dose of MENACTRA the other day with no reported adverse event; Initial information received on 02-Nov-2023 regarding an unsolicited valid non-serious case received from a Pharmacist. This case involves an unknown age and unknown gender patient where pharmacist states that one of their patient received an expired dose of meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] the other day with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine Solution for injection (lot U7492AA and expiration date- 26-Oct-2023) via unknown route in unknown administration site (strength: not provided) for Immunisation (expired product administered) (latency- same day) Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
COVID-19 vaccine administered after expiration. Vaccine expired 8/31/2022, administered 9/1/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 18.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient was administered Menactra 4 weeks after receiving a dose of Menactra instead of the ordered Men B vaccine with no reported adverse event; Patient was administered Menactra 4 weeks after receiving a dose of Menactra instead of the ordered Men B vaccine with no reported adverse event; Initial information received on 18-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 18 years old male patient who was administered meningococcal A-C-Y-W135 (D conj) vaccine [Menactra] 4 weeks after receiving a dose of menactra instead of the ordered men b vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 18-Aug-2022, the patient received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (D conj) vaccine once (formulation and strength not reported; lot U7492AA, expiry date: 26-Oct-2023) via intramuscular route in the left deltoid for immunization. On 18-Aug-2022 the patient was administered menactra 4 weeks after receiving a dose of menactra instead of the ordered men b vaccine with no reported adverse event (wrong product administered) and (extra dose administered) following the administration of meningococcal A-C-Y-W135 (D conj) vaccine. It was reported, the patient received MENACTRA 4 weeks ago 18JUL2022 and returned today for a Men B vaccine. The patient was mistakenly given this 2nd dose of MENACTRA within a 4 week time frame. Caller is also asking how long to wait before given MEN B since the patient did get an extra dose of MENACTRA. Action taken was not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 12.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
No adverse event
Symptomtext
12 yr old female was given Pfizer COVID vaccined that was formulated for a 5-11 yr old instead of the Pfizer COVID vaccine formulated for a 12 yr old and older. No signs or sysmtoms after vaccine was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Tdap and Menactra were given too early. Tdap not due for 9 years, and Menactra not due for 3 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None noted
- Allergien
- almonds, grass
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 24.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product use issue
Symptomtext
states patient had a dose of MENACTRA at age 11 and received the second dose 4 weeks ago. Caller states that patient did not need this third dose and was given mistakenly with no reported adverse event; Initial information received on 14-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 17 years old female patient who experienced states patient had a dose of menactra at age 11 and received the second dose 4 weeks ago. caller states that patient did not need this third dose and was given mistakenly with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO) for Immunisation. On 14-Jul-2022, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U7492AA via intramuscular route in the right deltoid. On 14-JUL-2022 the patient developed a non-serious states patient had a dose of menactra at age 11 and received the second dose 4 weeks ago. caller states that patient did not need this third dose and was given mistakenly with no reported adverse event (product use issue) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- BEXSERO
- Allergien
- -
- Vorherige Impfungen
- -